XOMA (XOMA) News Today $23.80 -0.80 (-3.25%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XOMA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period XOMA (NASDAQ:XOMA) Rating Increased to Buy at Wall Street ZenWall Street Zen upgraded shares of XOMA from a "hold" rating to a "buy" rating in a research report on Saturday.June 14 at 2:16 AM | marketbeat.comXOMA (NASDAQ:XOMA) Stock Rating Upgraded by Wall Street ZenWall Street Zen raised shares of XOMA from a "hold" rating to a "buy" rating in a report on Friday.June 2, 2025 | marketbeat.comHC Wainwright Issues Positive Outlook for XOMA EarningsXOMA Co. (NASDAQ:XOMA - Free Report) - Stock analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for shares of XOMA in a report issued on Wednesday, May 28th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn $0.06 per share for the quaMay 31, 2025 | marketbeat.comPositive Outlook for Xoma: Strategic Positioning and Pricing Dynamics Drive Buy RatingMay 29, 2025 | tipranks.comXOMA's (XOMA) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $104.00 target price on shares of XOMA in a report on Wednesday.May 29, 2025 | marketbeat.comXOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)May 28, 2025 | benzinga.comXOMA’s Strategic Expansion and Mezagitamab’s Market Potential Drive Buy RatingMay 28, 2025 | tipranks.comXOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 MillionMay 27, 2025 | globenewswire.comWoodline Partners LP Acquires 60,927 Shares of XOMA Co. (NASDAQ:XOMA)Woodline Partners LP increased its holdings in shares of XOMA Co. (NASDAQ:XOMA - Free Report) by 63.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,266 shares of the biotechnology company's stockMay 27, 2025 | marketbeat.comInsider Selling: XOMA Co. (NASDAQ:XOMA) CEO Sells 25,637 Shares of StockMay 22, 2025 | insidertrades.comBvf Partners L. P/Il Sells 392,723 Shares of XOMA Co. (NASDAQ:XOMA) StockMay 21, 2025 | insidertrades.comMajor Shareholder Sells Massive Chunk of Xoma Stock!May 20, 2025 | tipranks.comStonepine Capital Management LLC Reduces Stock Holdings in XOMA Co. (NASDAQ:XOMA)Stonepine Capital Management LLC lowered its stake in XOMA Co. (NASDAQ:XOMA - Free Report) by 35.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 125,700 shares of the biotechnology comMay 20, 2025 | marketbeat.comLeerink Partnrs Analysts Boost Earnings Estimates for XOMAXOMA Co. (NASDAQ:XOMA - Free Report) - Equities research analysts at Leerink Partnrs raised their Q2 2025 earnings estimates for shares of XOMA in a report issued on Thursday, May 15th. Leerink Partnrs analyst D. Risinger now expects that the biotechnology company will post earnings per share ofMay 20, 2025 | marketbeat.comXOMA Royalty First Quarter 2025 Earnings: Beats ExpectationsMay 15, 2025 | finance.yahoo.comXOMA Royalty: Q1 Earnings SnapshotMay 13, 2025 | sfgate.comXOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business AchievementsMay 13, 2025 | finance.yahoo.comXOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual ConferenceMay 7, 2025 | globenewswire.comXOMA (XOMA) Expected to Announce Quarterly Earnings on ThursdayXOMA (NASDAQ:XOMA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-xoma-co-stock/)May 3, 2025 | marketbeat.comHigh Growth Tech Stocks In The US To Watch April 2025April 22, 2025 | uk.finance.yahoo.comXOMA (NASDAQ:XOMA) Now Covered by BenchmarkBenchmark began coverage on shares of XOMA in a report on Thursday. They issued a "buy" rating and a $35.00 price target for the company.April 19, 2025 | marketbeat.comBenchmark Initiates Coverage of XOMA Royalty Corporation - Preferred Stock (XOMAP) with Buy RecommendationApril 18, 2025 | msn.comXoma initiated with a Buy at BenchmarkApril 17, 2025 | markets.businessinsider.comXoma (XOMA) Receives Buy Rating from Benchmark with Promising Growth Forecast | XOMA Stock NewsApril 17, 2025 | gurufocus.comXOMA Royalty Completes Sale of Kinnate Pipeline AssetsApril 14, 2025 | gurufocus.comXOMA (XOMA) Sells Kinnate Biopharma Pipeline Assets for Potential $270M | XOMA Stock NewsApril 14, 2025 | gurufocus.comXOMA Royalty Completes Sale of Kinnate Pipeline Assets | XOMA Stock NewsApril 14, 2025 | gurufocus.comXOMA Royalty Completes Sale of Kinnate Pipeline AssetsApril 14, 2025 | globenewswire.comXOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.comStockNews.com raised shares of XOMA from a "sell" rating to a "hold" rating in a report on Friday.April 13, 2025 | marketbeat.comInsider Buying: XOMA Co. (NASDAQ:XOMA) CIO Purchases 2,000 Shares of StockApril 10, 2025 | insidertrades.comXOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 9, 2025 | msn.comJoseph M. Limber Buys 5,243 Shares of XOMA Co. (NASDAQ:XOMA) StockApril 9, 2025 | insidertrades.comInsider Buying: XOMA Co. (NASDAQ:XOMA) Director Acquires 5,243 Shares of StockXOMA Co. (NASDAQ:XOMA - Get Free Report) Director Joseph M. Limber acquired 5,243 shares of the stock in a transaction dated Monday, April 7th. The stock was acquired at an average cost of $25.60 per share, with a total value of $134,220.80. Following the transaction, the director now owns 10,000 shares of the company's stock, valued at approximately $256,000. This trade represents a 110.22 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.April 9, 2025 | marketbeat.comXOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 SharesXOMA Co. (NASDAQ:XOMA - Get Free Report) Director Joseph M. Limber bought 17,935 shares of the firm's stock in a transaction on Thursday, April 3rd. The shares were acquired at an average cost of $25.24 per share, with a total value of $452,679.40. Following the purchase, the director now directly owns 16,524 shares of the company's stock, valued at approximately $417,065.76. This represents a -1,271.08 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.April 9, 2025 | marketbeat.comXOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech TwistApril 8, 2025 | seekingalpha.comXOMA (NASDAQ:XOMA) Rating Lowered to "Sell" at StockNews.comStockNews.com lowered XOMA from a "hold" rating to a "sell" rating in a report on Thursday.April 5, 2025 | marketbeat.comXOMA Royalty to Present at Jones Healthcare and Technology Innovation ConferenceApril 2, 2025 | globenewswire.comXOMA (NASDAQ:XOMA) Earns "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $104.00 price objective on shares of XOMA in a research report on Friday.March 29, 2025 | marketbeat.comXOMA Co. (NASDAQ:XOMA) CIO Bradley Sitko Purchases 4,134 SharesXOMA Co. (NASDAQ:XOMA - Get Free Report) CIO Bradley Sitko acquired 4,134 shares of the company's stock in a transaction that occurred on Friday, March 21st. The stock was acquired at an average cost of $23.89 per share, for a total transaction of $98,761.26. Following the acquisition, the executive now owns 10,484 shares of the company's stock, valued at $250,462.76. The trade was a 65.10 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.March 26, 2025 | marketbeat.comBradley Sitko Acquires 4,134 Shares of XOMA Co. (NASDAQ:XOMA) StockMarch 26, 2025 | insidertrades.comHC Wainwright Comments on XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a report issued on Wednesday, March 19th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology company will earn ($0.20) per shareMarch 22, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for XOMA EarningsXOMA Co. (NASDAQ:XOMA - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2025 earnings estimates for XOMA in a research note issued on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger now forecasts that the biotechnology company will post earnings per share of ($0.60)March 21, 2025 | marketbeat.comXOMA Preferred Shares Series A declares $0.539 dividendMarch 20, 2025 | seekingalpha.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendMarch 20, 2025 | seekingalpha.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | gurufocus.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | globenewswire.comLeerink Partnrs Estimates XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a research report issued to clients and investors on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger expects that the biotechnology company will poMarch 20, 2025 | marketbeat.comXOMA Royalty Full Year 2024 Earnings: EPS Misses ExpectationsMarch 19, 2025 | finance.yahoo.comXOMA Royalty Corp (XOMA) Reports Q4 EPS of -$0.30, Revenue of $8. ...March 19, 2025 | gurufocus.comXOMA (NASDAQ:XOMA) Releases Quarterly Earnings Results, Misses Expectations By $0.17 EPSXOMA (NASDAQ:XOMA - Get Free Report) issued its quarterly earnings data on Monday. The biotechnology company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.17). XOMA had a negative net margin of 151.34% and a negative return on equity of 24.95%.March 18, 2025 | marketbeat.com Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼1.450.88▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼22▲XOMA Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novavax News OPKO Health News Geron News Regulus Therapeutics News Zenas Biopharma News Myriad Genetics News Rigel Pharmaceuticals News Emergent BioSolutions News Verastem News Vanda Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
